Edward M. Kaye
Overview
Edward M. Kaye received an average of $6M in total compensation, including $597K in salary, at Stoke Therapeutics from 2021 to 2023. Edward Kaye also received an average of $3M at Sarepta Therapeutics from 2011 to 2017.
- 2023
- 2022
- 2021
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
Stoke TherapeuticsChief Executive Officer
Stoke TherapeuticsChief Executive Officer
Stoke TherapeuticsChief Executive Officer
Sarepta TherapeuticsFormer President and Chief Executive Officer
Sarepta TherapeuticsPresident and Chief Executive Officer
Sarepta TherapeuticsPresident and Chief Executive Officer
Sarepta TherapeuticsPresident and Chief Executive Officer
Sarepta TherapeuticsInterim Chief Executive Officer, and Senior Vice President, Chief Medical Officer
Sarepta TherapeuticsInterim Chief Executive Officer, Senior Vice President, Chief Medical Officer
Sarepta TherapeuticsSenior Vice President, Chief Medical Officer
Source: SEC filings on April 23, 2024, September 28, 2023, April 27, 2023, April 26, 2018, April 27, 2017, May 31, 2016, April 30, 2015, and April 30, 2013.
Related executives
We found 32 more executives who work or worked at Stoke Therapeutics and Sarepta Therapeutics.
Barry Ticho
Stoke Therapeutics
Chief Medical Officer
Stephen Tulipano
Stoke Therapeutics
Chief Financial Officer
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Ryan Brown
Sarepta Therapeutics
General Counsel
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
David Howton
Sarepta Therapeutics